Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
17.63
-0.50 (-2.76%)
Jun 27, 2025, 4:00 PM - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $566.98 million as of June 27, 2025. Its market cap has decreased by -19.37% in one year.
Market Cap
566.98M
Enterprise Value
236.84M
1-Year Change
-19.37%
Ranking
Category
Stock Price
$17.63
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $566.98M, an increase of 247.85%. That is a compound annual growth rate of 100.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 566.98M | -12.13% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |